Table 1.
Scenario | Coverage (%) | Scale-up (years) | Efficacy (%) | Durability (years) | Waning | Return rate for booster (%) |
---|---|---|---|---|---|---|
1 | 100 | 0 | 100 | 20 | No | NA |
2 | 100 | 5 | 100 | 20 | No | NA |
3 | 100 | 5 | 100 | 10 | No | NA |
4 | 100 | 5 | 50 | 10 | Yes | 100 |
5 | 60 | 5 | 50 | 10 | Yes | 100 |
6 | 30 | 5 | 50 | 10 | Yes | 100 |
7 | 10 | 5 | 50 | 10 | Yes | 100 |
8 | 100 | 5 | 50 | 10 | Yes | 80 |
9 | 60 | 5 | 50 | 10 | Yes | 80 |
10 | 30 | 5 | 50 | 10 | Yes | 80 |
11 | 10 | 5 | 50 | 10 | Yes | 80 |
12 | 100 | 5 | 50 | 10 | Yes | 50 |
13 | 60 | 5 | 50 | 10 | Yes | 50 |
14 | 30 | 5 | 50 | 10 | Yes | 50 |
15 | 10 | 5 | 50 | 10 | Yes | 50 |